Published in
Springer Nature [academic journals on nature.com], Prostate Cancer and Prostatic Diseases, 2021
DOI: 10.1038/s41391-021-00344-1
Links
Tools
The effects of new life-prolonging drugs for metastatic castration-resistant prostate cancer (mCRPC) patients in a real-world population
Journal article published in 2021 by
H. M. Westgeest 
,
M. C. P. Kuppen,
A. J. M. van den Eertwegh,
R. de Wit,
A. M. Bergman,
R. J. A. van Moorselaar,
J. L. L. M. Coenen,
A. C. M. van den Bergh,
D. M. Somford ,
N. Mehra ,
I. M. van Oort ,
K. K. H. Aben ,
W. R. Gerritsen ,
C. A. Uyl-De Groot
,
M. C. P. Kuppen,
A. J. M. van den Eertwegh,
R. de Wit,
A. M. Bergman,
R. J. A. van Moorselaar,
J. L. L. M. Coenen,
A. C. M. van den Bergh,
D. M. Somford ,
N. Mehra ,
I. M. van Oort ,
K. K. H. Aben ,
W. R. Gerritsen ,
C. A. Uyl-De Groot
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 